Suchen
Oncology Institute Inc
TOIZur Watchlist hinzufügen
5.130USD
0.0000.00%
Handelsschluss 08-03 16:00（ET）
652.26MMarktkapitalisierung
VerlustKGV TTM
Oncology Institute Inc (TOI) Umsatzentwicklung
Aktualisiert: Dec 31, 2025Nach Geschäftsbereich
Umsatz
Anteil
Jährlich
Jährlich
Vierteljährlich
Dispensary revenue
FFS revenue
Capitated revenue
Clinical research trials and other revenue
FY2025
FY2024
FY2023
FY2022
Dispensary revenue
269.18M(53.54%)
179.92M(45.73%)
103.83M(32.02%)
79.34M(31.43%)
FFS revenue
148.51M(29.54%)
136.20M(34.62%)
143.13M(44.14%)
105.44M(41.76%)
Capitated revenue
80.48M(16.01%)
68.69M(17.46%)
70.37M(21.70%)
61.34M(24.30%)
Clinical research trials and other revenue
4.56M(0.91%)
8.61M(2.19%)
6.90M(2.13%)
6.36M(2.52%)